Search

Kurt Fernstrom

Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )

Most Active Art Unit
3711
Art Unit(s)
3714, 3712, 3715, 3711
Total Applications
2669
Issued Applications
1756
Pending Applications
157
Abandoned Applications
755

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6351681 [patent_doc_number] => 20100021933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'CELLOMICS SYSTEMS' [patent_app_type] => utility [patent_app_number] => 12/471853 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 148451 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021933.pdf [firstpage_image] =>[orig_patent_app_number] => 12471853 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471853
CELLOMICS SYSTEMS May 25, 2009 Abandoned
Array ( [id] => 6549714 [patent_doc_number] => 20100016569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CELLOMICS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/472010 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 148451 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016569.pdf [firstpage_image] =>[orig_patent_app_number] => 12472010 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/472010
CELLOMICS SYSTEM May 25, 2009 Abandoned
Array ( [id] => 6549693 [patent_doc_number] => 20100016568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CELLOMICS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/471947 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 148450 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016568.pdf [firstpage_image] =>[orig_patent_app_number] => 12471947 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471947
CELLOMICS SYSTEM May 25, 2009 Abandoned
Array ( [id] => 5465015 [patent_doc_number] => 20090325215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'CELLOMICS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/472037 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 148480 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325215.pdf [firstpage_image] =>[orig_patent_app_number] => 12472037 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/472037
CELLOMICS SYSTEM May 25, 2009 Abandoned
Array ( [id] => 6333793 [patent_doc_number] => 20100018862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'CELLOMICS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/471993 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 148451 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20100018862.pdf [firstpage_image] =>[orig_patent_app_number] => 12471993 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471993
CELLOMICS SYSTEM May 25, 2009 Abandoned
Array ( [id] => 6083566 [patent_doc_number] => 20110144003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE' [patent_app_type] => utility [patent_app_number] => 12/993170 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11649 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144003.pdf [firstpage_image] =>[orig_patent_app_number] => 12993170 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993170
Maintenance therapy regime/regimen for the treatment of acne May 19, 2009 Issued
Array ( [id] => 6015002 [patent_doc_number] => 20110223242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAID NANOPARTICLES, AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS' [patent_app_type] => utility [patent_app_number] => 12/993664 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7660 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223242.pdf [firstpage_image] =>[orig_patent_app_number] => 12993664 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993664
Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors May 19, 2009 Issued
Array ( [id] => 6118674 [patent_doc_number] => 20110076347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Molecules Interfering with Binding of Calbindin to Inositol Monophosphatase for the Treatment of Mood Disorders' [patent_app_type] => utility [patent_app_number] => 12/991700 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4570 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076347.pdf [firstpage_image] =>[orig_patent_app_number] => 12991700 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/991700
Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders May 13, 2009 Issued
Array ( [id] => 6127686 [patent_doc_number] => 20110086807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'FIBROMODULIN FORMULATION FOR REDUCING CORNEAL SCARRING' [patent_app_type] => utility [patent_app_number] => 12/937324 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7972 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086807.pdf [firstpage_image] =>[orig_patent_app_number] => 12937324 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937324
Fibromodulin formulation for reducing corneal scarring Apr 30, 2009 Issued
Array ( [id] => 5959519 [patent_doc_number] => 20110183906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES' [patent_app_type] => utility [patent_app_number] => 12/989555 [patent_app_country] => US [patent_app_date] => 2009-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8822 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183906.pdf [firstpage_image] =>[orig_patent_app_number] => 12989555 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989555
FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES Apr 23, 2009 Abandoned
Array ( [id] => 5485718 [patent_doc_number] => 20090275483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'QUANTITATIVE MICROARRAY OF INTACT GLYCOLIPID CD1D INTERACTION AND CORRELATION WITH CELL-BASED CYTOKINE PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/423728 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6467 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275483.pdf [firstpage_image] =>[orig_patent_app_number] => 12423728 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/423728
Quantitative microarray of intact glycolipid CD1d interaction and correlation with cell-based cytokine production Apr 13, 2009 Issued
Array ( [id] => 10077509 [patent_doc_number] => 09115352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Method for the preparation of a nucleic acid library' [patent_app_type] => utility [patent_app_number] => 12/414174 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 8 [patent_no_of_words] => 24937 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 876 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12414174 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/414174
Method for the preparation of a nucleic acid library Mar 29, 2009 Issued
Array ( [id] => 5473721 [patent_doc_number] => 20090246887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Diamond Crystallites For Biotechnological Applications' [patent_app_type] => utility [patent_app_number] => 12/411241 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4348 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246887.pdf [firstpage_image] =>[orig_patent_app_number] => 12411241 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/411241
Diamond Crystallites For Biotechnological Applications Mar 24, 2009 Abandoned
Array ( [id] => 6145043 [patent_doc_number] => 20110130472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PROTEOSE PEPTONE FRACTION' [patent_app_type] => utility [patent_app_number] => 12/918523 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5840 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130472.pdf [firstpage_image] =>[orig_patent_app_number] => 12918523 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/918523
PROTEOSE PEPTONE FRACTION Feb 17, 2009 Abandoned
Array ( [id] => 6120759 [patent_doc_number] => 20110077189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'COMPOSITION FOR STIMULATING NATURAL KILLER CELL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/865310 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3993 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077189.pdf [firstpage_image] =>[orig_patent_app_number] => 12865310 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865310
COMPOSITION FOR STIMULATING NATURAL KILLER CELL ACTIVITY Jan 29, 2009 Abandoned
Array ( [id] => 7501497 [patent_doc_number] => 20110263504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE' [patent_app_type] => utility [patent_app_number] => 12/863973 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 49853 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263504.pdf [firstpage_image] =>[orig_patent_app_number] => 12863973 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/863973
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage Jan 21, 2009 Issued
Array ( [id] => 8063853 [patent_doc_number] => 20110245093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'FUNCTIONAL PROTEIN ARRAYS' [patent_app_type] => utility [patent_app_number] => 12/351465 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8501 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245093.pdf [firstpage_image] =>[orig_patent_app_number] => 12351465 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/351465
FUNCTIONAL PROTEIN ARRAYS Jan 8, 2009 Abandoned
Array ( [id] => 6446351 [patent_doc_number] => 20100279952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'CROSS-LINKED HYDROGEL CONTAINING AN ACTIVE SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 12/747435 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4318 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279952.pdf [firstpage_image] =>[orig_patent_app_number] => 12747435 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/747435
CROSS-LINKED HYDROGEL CONTAINING AN ACTIVE SUBSTANCE Dec 21, 2008 Abandoned
Array ( [id] => 6446158 [patent_doc_number] => 20100279934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/810470 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12769 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279934.pdf [firstpage_image] =>[orig_patent_app_number] => 12810470 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/810470
TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES Dec 18, 2008 Abandoned
Array ( [id] => 8870881 [patent_doc_number] => 08466258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis' [patent_app_type] => utility [patent_app_number] => 12/746996 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12717 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746996 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/746996
Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis Dec 10, 2008 Issued
Menu